Total debt rose to $215.4M against equity of $244.7M, lifting the debt-to-equity ratio to 0.88 from 0.39 a year earlier, which suggests growth is increasingly financed by borrowing while the current ratio of 4.16 provides a liquidity cushion.
GeneDx Holdings Corp. (WGS) balance sheet — 6-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 |
|---|
| Total Current Assets | 296.89M | 268.29M | 197.97M | 182.34M | 212.62M | 483.54M | 174.11M |
| Cash & Short-Term Investments | 170.12M | 171.28M | 141.19M | 130.15M | 137.4M | 400.57M | 108.13M |
| Cash Only | 96.14M | 105M | 85.21M | 99.68M | 137.4M | 400.57M | 108.13M |
| Short-Term Investments | 73.98M | 66.28M | 55.97M | 30.47M | 0 | 0 | 0 |
| Accounts Receivable | 92.13M | 74.37M | 37.63M | 32.82M | 43.34M | 26.56M | 32.33M |
| Days Sales Outstanding | 64.76 | 63.49 | 44.97 | 59.13 | 67.41 | 45.69 | 65.81 |
| Inventory | 21.7M | 13.95M | 10.65M | 8.78M | 13.66M | 33.46M | 24.96M |
| Days Inventory Outstanding | 40.15 | 39.36 | 35 | 28.46 | 19.08 | 53.37 | 51.98 |
| Other Current Assets | 1.64M | 1.51M | 1.08M | 1.96M | 6.39M | 3.8M | 4.12M |
| Total Non-Current Assets | 229.59M | 255.42M | 221.41M | 236.42M | 332.64M | 70.55M | 77.53M |
| Property, Plant & Equipment | 85.94M | 69.11M | 58.51M | 59.38M | 84.28M | 62.72M | 63.11M |
| Fixed Asset Turnover | 5.62x | 6.19x | 5.22x | 3.41x | 2.78x | 3.38x | 2.84x |
| Goodwill | 1.64M | 13.52M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 137.73M | 168.48M | 158.6M | 172.63M | 186.65M | 0 | 0 |
| Long-Term Investments | 993K | 0 | 0 | 0 | 900K | 900K | 10.83M |
| Other Non-Current Assets | 4.28M | 4.32M | 4.31M | 4.41M | 6.48M | 6.93M | 3.6M |
| Total Assets | 526.48M | 523.71M | 419.38M | 418.76M | 545.26M | 554.09M | 251.64M |
| Asset Turnover | 0.88x | 0.82x | 0.73x | 0.48x | 0.43x | 0.38x | 0.71x |
| Asset Growth % | 59.77% | 24.88% | 0.15% | -23.2% | -1.59% | 120.19% | - |
| Total Current Liabilities | 71.4M | 108.91M | 54.82M | 58.82M | 144.3M | 101.28M | 73.44M |
| Accounts Payable | 3.32M | 2.46M | 7.95M | 10.24M | 46.02M | 44.69M | 26.74M |
| Days Payables Outstanding | 13.5 | 6.94 | 26.14 | 33.2 | 64.24 | 71.3 | 55.67 |
| Short-Term Debt | 0 | 4.54M | 0 | 497K | 10.87M | 3.42M | 3.51M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 40K | 473K | 1.78M |
| Other Current Liabilities | 33.15M | 52.2M | 30.42M | 30.88M | 67.08M | 52.7M | 41.42M |
| Current Ratio | 4.16x | 2.46x | 3.61x | 3.10x | 1.47x | 4.77x | 2.37x |
| Quick Ratio | 3.85x | 2.34x | 3.42x | 2.95x | 1.38x | 4.44x | 2.03x |
| Cash Conversion Cycle | 91.42 | 95.91 | 53.83 | 54.39 | 22.24 | 27.77 | 62.12 |
| Total Non-Current Liabilities | 210.39M | 106.62M | 119.32M | 131.92M | 147.26M | 64.71M | 173.81M |
| Long-Term Debt | 146.23M | 48.18M | 51.91M | 52.69M | 6.25M | 11M | 18.97M |
| Capital Lease Obligations | 250.57M | 56.05M | 60.92M | 62.94M | 60.01M | 18.43M | 20.78M |
| Deferred Tax Liabilities | 50.27M | 757K | 965K | 1.56M | 56.98M | 0 | 0 |
| Other Non-Current Liabilities | 71K | 1.64M | 5.52M | 14.73M | 24.02M | 35.28M | 134.06M |
| Total Liabilities | 281.8M | 215.53M | 174.13M | 190.74M | 291.56M | 165.99M | 247.25M |
| Total Debt | 215.38M | 113.17M | 116.17M | 119.77M | 77.13M | 32.85M | 43.26M |
| Net Debt | 119.25M | 8.17M | 30.96M | 20.09M | -60.27M | -367.72M | -64.88M |
| Debt / Equity | 0.88x | 0.37x | 0.47x | 0.53x | 0.30x | 0.08x | 9.86x |
| Debt / EBITDA | -5.32x | 8.43x | - | - | - | - | - |
| Net Debt / EBITDA | -2.95x | 0.61x | - | - | - | - | - |
| Interest Coverage | -25.47x | -7.32x | -16.36x | - | -142.66x | -85.56x | -96.55x |
| Total Equity | 244.69M | 308.18M | 245.25M | 228.02M | 253.71M | 388.1M | 4.39M |
| Equity Growth % | -3.76% | 25.66% | 7.56% | -10.13% | -34.63% | 8744.64% | - |
| Book Value per Share | 8.19 | 11.46 | 9.12 | 9.38 | 24.78 | 118.50 | 0.78 |
| Total Shareholders' Equity | 244.69M | 308.18M | 245.25M | 228.02M | 253.71M | 388.1M | 4.39M |
| Common Stock | 3K | 3K | 2K | 2K | 38K | 24K | 0 |
| Retained Earnings | -1.47B | -1.37B | -1.35B | -1.3B | -1.12B | -575.44M | -330.05M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -111K | 936K | 830K | 425K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying WGS stock.
As of 2025, GeneDx Holdings Corp. (WGS) had total assets of $523.7M including $268.3M in current assets.
GeneDx Holdings Corp. (WGS) carries total debt of $113.2M, offset by $171.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
GeneDx Holdings Corp. (WGS) has total shareholders' equity (book value) of $308.2M ($11.46 book value per share). Book value represents the net worth of the company belonging to common stock holders.
GeneDx Holdings Corp. (WGS) reported a current ratio of 2.46x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Persistent cash burn and debt growth
Metrics are mathematically derived from official filings.
Balance Sheet Expanding Alongside Leverage Build
According to reported quarterly figures, WGS total assets rose from $389.1M in Q2 2024 to $526.5M in Q3 2026 while total debt climbed from $117.0M to $215.4M, indicating growth financed increasingly by borrowing.
The expansion in total assets suggests the business is scaling its operating base, but the faster rise in debt relative to equity points to a balance sheet being stretched rather than strengthened. Investors should monitor whether incremental debt is funding productive capacity or simply bridging continued operating losses. The shift in the debt-to-equity ratio from roughly 0.60 to 0.88 warrants close attention given the company's ongoing negative retained earnings.
Debt Growth Outpacing Equity Base
Based on reported figures, total debt increased by roughly 84% over ten quarters to $215.4M in Q3 2026, lifting the debt-to-equity ratio to 0.88 from 0.39 in Q3 2025.
The rapid acceleration in leverage over the past year suggests the company is relying on debt to support its cash needs rather than retained profits. Given that operating cash flow remains negative, debt service capacity depends on continued access to capital markets or a sustained improvement in operations. Refinancing terms and maturity profile are not available in the supplied data and should be examined before drawing firm conclusions on repayment risk.
Current Ratio Strong but Cash Thin
As reported in the quarterly balance sheet, WGS's current ratio stood at 4.16 in Q3 2026 with cash of $96.1M, though this headline liquidity cushion sits against recurring operating cash outflows.
A current ratio above 4 appears comfortable on paper, but the cash balance covers only a limited number of quarters at recent burn rates, implying the liquidity buffer is more modest than the ratio alone suggests. The large share of current assets that may be receivables rather than cash adds uncertainty to near-term flexibility. Investors should monitor how quickly cash is consumed relative to the debt-funded balance sheet expansion.
Equity Rebuilt Yet Accumulated Deficit Persists
Based on reported figures, shareholders' equity recovered from $194.0M in Q2 2024 to $244.7M in Q3 2026, but retained earnings remain near -$1.5B, reflecting a long history of losses.
Equity growth appears driven largely by capital raised rather than earnings, given the persistent accumulated deficit. This suggests the equity base depends on external financing and remains vulnerable to further dilution if losses continue. Stock-based compensation adds ongoing dilution pressure that should be considered alongside the reported equity figures.
Goodwill Write-Down Flatters Asset Quality
According to reported balance sheets, goodwill fell from $165.6M in Q2 2024 to $1.6M in Q3 2026, a sharp reduction that makes the current asset base look cleaner than the historical trend implies.
The large goodwill reduction suggests prior acquisitions were written down or divested, which lowers the risk of future impairment but also signals that past capital deployment did not generate the expected value. Headline asset growth therefore reflects a different composition than before, with a smaller intangible share. Investors should treat the cleaner asset quality as partly the product of earlier write-offs rather than purely organic strength.